undamentalytics Newsletter
Sign in

Phibro Animal Health Corp key statistics and ratios

In fiscal 2026, Phibro Animal Health Corp had return on equity of 29.7% and a net margin of 6.6%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2012Jun 20122013Jun 20132014Jun 20142015Jun 20152016Jun 20162017Jun 20172018Jun 20182019Jun 20192020Jun 20202021Jun 20212022Jun 20222023Jun 20232024Jun 20242025Jun 20252026Jun 2026
Net margin1.1%3.8%−0.5%8.1%11.0%8.5%7.9%6.6%4.2%6.5%5.2%3.3%0.2%3.7%6.6%
Return on equity————137.8%53.5%38.6%27.3%16.6%25.5%19.6%12.0%0.9%17.8%29.7%
Return on assets—5.2%−0.7%12.5%15.0%10.5%10.0%7.8%4.4%6.7%5.5%3.4%0.2%4.1%7.0%
Effective tax rate46.8%−39.5%—23.5%−7.8%19.8%26.3%23.5%39.6%18.2%32.0%39.7%77.9%29.0%27.4%
R&D as % of revenue1.1%1.0%1.2%1.3%1.5%1.2%1.2%1.5%1.7%2.1%2.2%2.5%2.9%1.8%1.6%
SG&A as % of revenue17.6%18.7%20.3%19.5%20.4%19.7%20.5%21.9%23.5%23.6%21.9%23.2%25.5%22.3%21.0%
Dividends ÷ net income—12.1%—25.9%19.0%24.5%24.8%34.0%57.9%35.7%39.5%59.6%804.7%40.3%19.5%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

2 of 3 checks passed · June 30, 2026
What it owns · $1.5bn
Short-term assets $936mLonger-term assets $566m
What it owes, and who funded it · $1.5bn
Short-term liabilities $316mLonger-term liabilities $799mShareholders' equity $385m
  • Short-term assets cover short-term liabilities $936m of assets due within a year against $316m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $936m short-term assets against $799m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of $194m against $46m of interest.

From Phibro Animal Health Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

49 /100

Moderate moat

How hard Phibro Animal Health's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 7 / 20

    Cash operating profit has been a median 6.6% of total assets over 10 years.

  • Pricing power 12 / 20

    Gross margin has been a median 32.0%, moving by 1.1 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median 8.8%; its worst year was 5.2%.

  • Cash conversion 9 / 20

    Free cash flow was positive in 8 of 10 years, at a median 2.7% of revenue.

  • Discipline 16 / 20

    The diluted share count rose 1.1% over five years; stock-based pay has been a median 0.1% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (54 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: LNTH vs PAHCINDV vs PAHCPAHC vs TRLV

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Phibro Animal Health Corp's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Phibro Animal Health Corp.